In the 7-06-04 issue of Inside Bioassays, the article “BD Biosciences Strengthens its High-Content Screening Portfolio with Atto Purchase” (see Inside Bioassays, 7/6/2004), mistakenly identified Life Technologies, a company subsequently acquired by Invitrogen, as Life Sciences.
Correction: Jul 13, 2004
Premium